$18.26
-0.84[-4.40%]
At close: May 17
$18.26
0[0.00%]
After Hours: 4:00PM EDT
Tyra Biosciences
(NASDAQ:TYRA)Tyra Biosciences Stock (NASDAQ:TYRA), Analyst Ratings, Price Targets, Predictions
Tyra Biosciences Inc has a consensus price target of $20, established from looking at the 24 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, Wedbush, and HC Wainwright & Co. on May 13, 2024, May 10, 2024, and May 10, 2024. With an average price target of $26.33 between Oppenheimer, Wedbush, and HC Wainwright & Co., there's an implied 44.21% upside for Tyra Biosciences Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
Wedbush
HC Wainwright & Co.
HC Wainwright & Co.
Jefferies
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Tyra Biosciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/13/2024 | Buy Now | 53.34% | Oppenheimer | Matthew Biegler | $25 → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2024 | Buy Now | 53.34% | Wedbush | Robert Driscoll | → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2024 | Buy Now | 25.96% | HC Wainwright & Co. | Mitchell Kapoor | → $23 | Reiterates | Buy → Buy | Get Alert |
| 03/21/2024 | Buy Now | 53.34% | Wedbush | Robert Driscoll | → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 03/20/2024 | Buy Now | 25.96% | HC Wainwright & Co. | Mitchell Kapoor | $19 → $23 | Reiterates | Buy → Buy | Get Alert |
| 12/29/2023 | Buy Now | 47.86% | Wedbush | Robert Driscoll | $27 → $27 | Reiterates | Outperform → Outperform | Get Alert |
| 12/26/2023 | Buy Now | 4.05% | HC Wainwright & Co. | Mitchell Kapoor | → $19 | Reiterates | Buy → Buy | Get Alert |
| 11/08/2023 | Buy Now | 4.05% | HC Wainwright & Co. | Mitchell Kapoor | $20 → $19 | Maintains | Buy | Get Alert |
| 08/11/2023 | Buy Now | 47.86% | Wedbush | Robert Driscoll | → $27 | Reiterates | Outperform → Outperform | Get Alert |
| 08/11/2023 | Buy Now | 9.53% | HC Wainwright & Co. | Mitchell Kapoor | $17 → $20 | Maintains | Buy | Get Alert |
| 08/01/2023 | Buy Now | -6.9% | HC Wainwright & Co. | Mitchell Kapoor | → $17 | Reiterates | Buy → Buy | Get Alert |
| 06/30/2023 | Buy Now | 47.86% | Wedbush | Robert Driscoll | → $27 | Initiates | → Outperform | Get Alert |
| 05/08/2023 | Buy Now | 36.91% | Oppenheimer | Matthew Biegler | → $25 | Reiterates | → Outperform | Get Alert |
| 05/05/2023 | Buy Now | -6.9% | HC Wainwright & Co. | Mitchell Kapoor | → $17 | Reiterates | → Buy | Get Alert |
| 03/23/2023 | Buy Now | -6.9% | HC Wainwright & Co. | Mitchell Kapoor | → $17 | Reiterates | → Buy | Get Alert |
| 03/07/2023 | Buy Now | -6.9% | HC Wainwright & Co. | Mitchell Kapoor | $15 → $17 | Maintains | Buy | Get Alert |
| 03/02/2023 | Buy Now | -17.85% | HC Wainwright & Co. | Mitchell Kapoor | $12 → $15 | Maintains | Buy | Get Alert |
| 02/03/2023 | Buy Now | -6.9% | Oppenheimer | Matthew Biegler | → $17 | Initiates | → Outperform | Get Alert |
| 06/23/2022 | Buy Now | -34.28% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Initiates | → Buy | Get Alert |
| 03/08/2022 | Buy Now | 47.86% | Jefferies | Maury Raycroft | $31 → $27 | Upgrade | Hold → Buy | Get Alert |
| 11/08/2021 | Buy Now | 69.77% | Jefferies | Maury Raycroft | — | Downgrade | Buy → Hold | Get Alert |
| 10/11/2021 | Buy Now | 20.48% | B of A Securities | Geoff Meacham | — | Initiates | → Buy | Get Alert |
| 10/11/2021 | Buy Now | 4.05% | Jefferies | Maury Raycroft | — | Initiates | → Buy | Get Alert |
| 10/11/2021 | Buy Now | — | Cowen & Co. | Tyler Van Buren | — | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Tyra Biosciences (TYRA)?
The latest price target for Tyra Biosciences (NASDAQ: TYRA) was reported by Oppenheimer on May 13, 2024. The analyst firm set a price target for $28.00 expecting TYRA to rise to within 12 months (a possible 53.34% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tyra Biosciences (TYRA)?
The latest analyst rating for Tyra Biosciences (NASDAQ: TYRA) was provided by Oppenheimer, and Tyra Biosciences reiterated their outperform rating.
When was the last upgrade for Tyra Biosciences (TYRA)?
The last upgrade for Tyra Biosciences Inc happened on March 8, 2022 when Jefferies raised their price target to $27. Jefferies previously had a hold for Tyra Biosciences Inc.
When was the last downgrade for Tyra Biosciences (TYRA)?
The last downgrade for Tyra Biosciences Inc happened on November 8, 2021 when Jefferies changed their price target from $19 to $31 for Tyra Biosciences Inc.
When is the next analyst rating going to be posted or updated for Tyra Biosciences (TYRA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tyra Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tyra Biosciences was filed on May 13, 2024 so you should expect the next rating to be made available sometime around May 13, 2025.
Is the Analyst Rating Tyra Biosciences (TYRA) correct?
While ratings are subjective and will change, the latest Tyra Biosciences (TYRA) rating was a reiterated with a price target of $25.00 to $28.00. The current price Tyra Biosciences (TYRA) is trading at is $18.26, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.